Table 4.

Overall presence of chronic/recurrent conditions

	Total (n = 1291)		T (n = 691)		HP (n = 199)		LP (n = 371)
	n	%	n	%	n	%	n	%
UTI	567	45.3	319	46.2	95	48.3	153	42.0
Pressure ulcer	527	41.5	255	36.9	112	55.0	160	42.6	1,3
Pain	501	39.8	239	34.6	78	40.2	184	49.2	2
DM	416	33.0	219	31.7	74	37.8	123	32.7
Hyper-lipidemia/cholesterolemia	379	30.2	183	26.5	59	30.6	137	36.7	2
Kidney/bladder disorders	323	25.6	178	25.8	51	24.9	94	25.8
PTSD anxiety	186	14.9	104	15.1	17	9.6	65	17.6
Depressive disorder	178	14.2	90	13.0	25	13.4	63	16.8
CAD	174	13.9	69	10.0	36	19.1	69	18.4	1,2
OA	159	12.5	84	12.2	24	11.5	51	13.8
Anemia	154	12.1	71	10.3	35	17.2	48	12.8	1
GERD	152	12.0	75	10.9	26	12.9	51	13.6
Bowel dysfunction	134	10.6	69	10.0	34	16.7	31	8.2	3
Benign prostatic hyperplasia	130	10.2	63	9.1	23	11.0	44	11.7
Urinary incontinence	128	10.2	73	10.6	24	12.4	31	8.2
Arrhythmia	119	9.5	58	8.4	32	15.8	29	8.0	1,3
Peripheral vascular disease	119	9.3	51	7.4	23	11.0	45	12.0	2
Lung diseases	112	8.8	66	9.6	23	11.0	23	6.1
Cancer	95	7.4	50	7.2	17	8.5	28	7.4
Mental disorder	92	7.3	52	7.5	15	7.7	25	6.6
COPD	75	5.9	43	6.2	13	6.2	19	5.1
ED	73	5.7	30	4.3	10	4.8	33	8.8	2
CHF	59	4.7	26	3.8	19	9.6	14	3.7
Substance use	47	3.7	32	4.6	2	1.0	13	3.5
CKD	48	3.6	17	2.5	9	4.3	22	5.9	2

PTSD, posttraumatic stress disorder; GERD, gastro-esophageal reflux disorder; COPD, chronic obstructive pulmonary disease; ED, erectile dysfunction; CHF, congestive heart failure; CKD, chronic kidney disease.

1, T vs. HP; 2, T vs. LP; 3, HP vs. LP significant at P < 0.05 after controlling for time trend